Practical relevance: There has been increasing identification of vector-borne pathogens in cats presented to veterinary clinics around the world for evaluation of fever and the associated secondary effects, such as signs of depression and loss of appetite. Aim: The aim of this article is to summarize the clinically relevant information concerning fever in cats that is associated with pathogens vectored by ticks or sandflies, with an emphasis on presenting clinical abnormalities and optimal diagnostic, treatment and prevention strategies. Fever in cats associated with pathogens known or suspected to be vectored by fleas was discussed within Part 1 of this two-part article series.
INTRODUCTION
In Part 1 of this two-part article series, the two major differentials for elevated body temperature (>39.2°C, 102.5°F) in cats -hyperthermia and fever (pyrexia) -were discussed and the infectious disease agents proven or likely to be vectored by fleas were summarized. 1 Here, in Part 2, which reviews the infectious disease agents vectored by ticks or sandflies, emphasis is placed on common clinical and laboratory findings, optimal diagnostic tests, treatments and strategies for prevention. Cats with fever, with or without thrombocytopenia, residing in Ixodes species-endemic areas should have blood smears examined cytologically to attempt to find morulae ( Figure 1 ). 9 Many commercial laboratories offer PCR assays to amplify A phago cytophilum DNA from blood and these assays are more likely to be positive than serologic tests in acute illness (Table 1 ). 2 One commercial assay for the detection of A phagocytophilum antibodies in dog serum (SNAP 4DXPlus; IDEXX Laboratories) has been shown to detect these antibodies in feline serum. 2 Approximately 30% of cats with proven clinical infections induced by A phagocytophilum are seronegative when first assessed serologically, but most of the proven cases evaluated to date have ultimately seroconverted. 5 Several antibiotics have been administered to naturally infected cats with suspected anaplasmosis. In two studies all cats became clinically normal within 24-48 h of initiation of tetracycline or doxycycline administration and recurrence was not reported. 5, 6, 9 Two cats were still PCR positive 17 days and 90 days after treatment (of 21-30 days' duration) while clinically normal, which suggests that treatment with tetracyclines for ⩽30 days may be inadequate for eliminating this pathogen from some cats. 5 The risk of infection in cats by A phagocytophilum should be reduced by appropriate use of an acaricide. However, in one study, purchase of a topical acaricide was not associated with a lessened risk of having antibodies against A phagocytophilum or B burgdorferi. 12 In that study, it appeared that owners of treated, seropositive cats did not administer the acaricide all year round. It is also possible that owners of cats with known exposure, and possibly previous infections, were more likely to purchase an acaracide.
Anaplasma platys
A number of cats have been shown to be infected by Anaplasma platys. [14] [15] [16] [17] This agent is suspected to be tick-borne, possibly by Rhipicephalus sanguineus. However, whether this agent induces fever in cats alone or as a coinfection has not been determined. Serologic tests have not been validated for this organism in cats. Thus, the diagnosis currently is based on the detection of morulae in platelets or amplification of specific DNA by PCR assay. Optimal treatments are unknown for cats, but doxycycline should be effective. Use of acaricides should lessen the risk of exposure.
Ehrlichia species
While canine ehrlichiosis is well characterized, less is known about the agents associated with disease in cats. It is likely that any country that has Ehrlichia canis infections in dogs also has E canis infections in cats. Naturally exposed cats in many countries have variously been shown to have Ehrlichia-like bodies or morulae in peripheral lymphocytes or monocytes, had DNA consistent with E canis amplified from the blood or tissues, or had antibodies that react to E canis morulae or peptides. 10, 13, [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] There have been field cases that have been positive for DNA identical to E canis at two genes that never seroconverted. 21 Another study reported that cats at greater risk for R sanguineus infestation were more likely to have higher prevalence rates (9.4%) of PCR positivity for E canis DNA. 26 In Sicily, E canis DNA was amplified from ticks collected from cats. 31 Fever, lethargy and inappetence are commonly reported clinical abnormalities in cats with suspected ehrlichiosis and so testing may be indicated in cats showing these signs. Thrombocytopenia, anemia and monocytosis appear to be the most common clinical laboratory findings in naturally infected cats. 19, 20, 25, 30 Almost every abnormality noted in dogs with clinical ehrlichiosis has been detected in cats, including monoclonal gammopathy.
A validated serologic assay is not currently available and some cats with E canis-like DNA in blood have been seronegative. 21 Positive serologic test results occur in both healthy and clinically ill cats, and so a diagnosis of clinical ehrlichiosis should not be based on serologic test results alone. Ehrlichia species PCR and gene sequencing can be used in cats with suspicious clinical signs to confirm infection and should be considered the tests of choice at this time. However, not all cats that are PCR positive are clinically ill.
Clinical improvement after treatment with tetracycline, doxycycline or imidocarb dipropionate has been reported for most cats with suspected ehrlichiosis. [19] [20] [21] 32 This short transmission time indicates the importance of using acaricides that either rapidly kill attached ticks or, preferably, prevent ticks from biting in the first place.
Rickettsia species
Rickettsia conorii and Rickettsia massiliae DNA was amplified or antibodies reacted to R conorii from the blood of cats in Spain and Italy. 13, 33 In one study of cats in the USA with fever, the Rickettsia rickettsii antibody prevalence rate was 6.6%, but DNA of the agent was not amplified from blood. 34 Similar results were seen in a study of cats in St Kitts, West Indies where 22/52 feral cats had R rickettsii antibodies in serum but were all negative for specific DNA in blood. 18 These results prove that cats are sometimes exposed to tick-borne spotted fever group organisms, but further data are needed to determine the significance of disease associations such as fever. Because clinical illness in cats has not been documented, optimal treatment is unknown. However, based on results in dogs, doxycycline or a fluoroquinolone would be logical choices. Use of acaricides should lessen the potential for transmission of these agents to cats.
Other bacteria
Borrelia species Many cats exposed to Ixodes species in North America and parts of Europe develop antibodies against B burgdorferi. Some cats are also infected by Borrelia persica from infestation by Ornithodoros tholozani in some parts of the Middle East. 35 Fever can be associated with B burgdorferi or B persica infections in cats. 12, 35, 36 However, since many cats have exposure to Ixodes species, it can be difficult to determine whether clinical illness is resulting from A phagocytophilum or B burgdorferi or both. 12 Cats with fever and suspected B persica infections should have peripheral blood smears evaluated for spirochetes and the infection can be confirmed by PCR assay. 35 While not approved for this use, serum from cats with fever and suspected B burgdorferi infection can be screened with a commercially available kit (SNAP 4DXPlus; IDEXX Laboratories) titrated for use with dog sera. 2, 4 However, a positive B burgdorferi antibody assay result proves only exposure, and not necessarily clinical borreliosis.
Cats with fever from suspected borreliosis generally respond to the administration of doxycycline at 5 mg/kg PO q12h or 10 mg/kg PO q24h. 12, 36 The effectiveness of different acaricides for the prevention of transmission of Borrelia species to cats has not been compared but, based on experiences in dogs, potentially all should be helpful in preventing borreliosis in cats if used appropriately. 37
Francisella tularensis
Cats in the USA can develop fever after infection by Francisella tularensis. 38 Cats are often infected by F tularensis through carnivorism but tick-borne transmission can occur. Infection can be proven by culture, amplification of specific DNA by PCR assay or rising antibody titers. 39 Clin ically ill cats should respond to doxycycline or fluoroquinolones. Cats in endemic areas should be provided with tick control all year round and hunting behavior should be minimized if possible.
Protozoa

Babesia species
In South Africa and parts of Asia, there is a high number of Babesia species that infect cats. In Europe, Babesia vogeli or Babesia vulpes DNA have been amplified from ticks collected from cats and antibodies reactive to B vulpes detected in cats. 13, 31, 37, 40 In the Americas, B vogeli and Babesia gibsoni have been described in cats as both single and mixed infections. 18, 41 B vogeli and Babesia canis are likely more prevalent in areas with high infestation rates for R sanguineus. However, whether these agents induce fever in cats alone or as a coinfection has not been determined.
Serologic tests have not been validated for these agents in cats. Thus, the diagnosis currently is based on detection of piroplasms in erythrocytes or amplification of specific DNA by PCR assay. Optimal treatments are unknown for cats but options primarily extrapolated from canine babesiosis have been reviewed. 42 Use of acaricides should lessen the risk of exposure, except for B gibsoni which may be transmitted directly.
Cytauxzoon species
Cats in the USA, Brazil and Europe can be infected by Cytauxzoon species. 10, [43] [44] [45] [46] [47] [48] [49] It is apparent that Cytauxzoon felis infections in the USA (transmitted by Amblyomma americanum) can be very pathogenic when compared with the Cytauxzoon species infections occurring in cats in other countries. This may represent different species in different countries. 50 While fatal C felis infections are common in some regions of the USA, cats that survive or have subclinical infections are also common. 51, 52 These findings suggest that a wide range of clinical presentations may occur, with differences among cats perhaps related to inoculation dose, pre-existing immunity, strain variations, or as yet unidentified variations in immune response of the cat. A recent study showed that C felis could be transmitted after 36-48 h of tick attachment, and that ingestion of A americanum did not induce infections. 53 In the USA, clinical infections are recognized most commonly in the spring, summer and fall. Owners of clinically affected cats report nonspecific complaints, such as lethargy and anorexia, frequently. Cats have fever or hypothermia if presented in the final shock phase of infection. Common physical examination findings that might lead to consideration of this agent as a differential diagnosis include unresponsive fever, pale mucous membranes from shock or anemia, icterus, splenomegaly and hepatomegaly. 10, 45 Discomfort, clinical evidence of central nervous system disease including seizures, tachypnea with or without dyspnea, and sudden death on manipulation may all occur. Recently, ocular involvement of cytauxzoonosis has been described. 54 Cytauxzoon species can be seen on erythrocytes frequently, but cytology can be falsely negative in the acute stages of illness. The serious clinical signs of disease relate to the development of shizonts in the tissues. The syndrome can be diagnosed by cytological demon stration of piroplasms on erythrocytes or shizonts in spleen, liver or bone marrow samples, or by amplification of Cytauxzoon species DNA in blood or tissue aspirates by PCR. 45 To date, clinically affected cats have shown the best response to a combination of azithromycin at 10 mg/kg PO q24h and atovaquone at 15 mg/kg PO q8h, with approximately 60% of treated cats responding. 55, 56 This combination is superior to diminazene or imidocarb protocols. 57 Minimal restraint techniques should be used during the administration of supportive care to lessen the likelihood of sudden death.
The poor overall treatment response in clinical cytauxzoonosis cases is a perfect example of why tick control can be so important. Again, as referred to earlier in this article series, it is always better to prevent a vector-borne disease than attempt to treat it after illness has begun. Appropriate use of acaracides should lessen the risk of transmission of this agent. 58 One commercially available flea and tick collar containing flumethrin (Seresto; Bayer Animal Health) and a topical product containing sarolaner (Selamectin Plus; Zoetis) were shown to block transmission of C felis by A americanum. 58, 59 Hepatozoon species A number of investigators have amplified Hepatozoon species DNA from cats and the agent has been detected in ticks collected from cats. 3, 28, 47, [60] [61] [62] In a recent report on cats in southern Italy, three different Hepatozoon species were detected. 61 In dogs, Hepatozoon americanum infection is induced by ingestion of ticks or ingestion of prey species such as rabbits. 63 Whether carnivorism results in infection of cats with Hepatozoon species has not been determined.
Fever associated with Hepatozoon species has not been studied extensively in cats; however, in dogs in the USA with H americanum infection, fever is common. In one study from Israel, fever was reported as one of the potential clinical manifestations of hepatozoonosis in cats. 60 PCR assays can be used to help confirm the diagnosis but optimal treatment protocols for cats with Hepatozoon species infections are unknown. Use of acaricides should lessen the potential for transmission of these agents among cats.
SANDFLY-BORNE AGENTS ASSOCIATED WITH FEVER
Leishmania species
Feline leishmaniosis has been reported globally. 62, [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] Traditionally skin lesions have been described as the most frequent clinical manifestation and sometimes were the only finding on physical examination. However, more recently cats have been described that do not have cutaneous manifestations but rather have other clinical signs, and in general these cases appear to be associated with a worse prognosis. A case of fever in a cat that may have related to leishmaniosis has been reported. 75 The diagnosis of leishmaniosis in cats, in the presence of suspected clinical signs, can be achieved using direct techniques such as cytology (Figure 2 ), histopathology and PCR assays. Alternatively, serologic techniques such as indirect fluorescent antibody assays or ELISAs that evaluate the immune response of the cat against Leishmania species can be used indirectly to support the diagnosis. In contrast to dogs that can have very high antibody levels even when subclinical carriers, a low positive titer in cats can be considered highly suggestive of a diagnosis of leishmaniosis. 76 Information about the best management of feline leishmaniosis is mostly based on single case reports. Long-term administration of allopurinol (10-20 mg/kg q12h or q24h) is usually clinically effective, but meglumine antimoniate has also been used successfully in a few cases. However, in the majority of cats the infection cannot be cleared, so the use of adequate prevention, including sandfly control, is recommended to reduce the number of cats infected with Leishmania species in endemic areas. 77, 78 JFMS CLINICAL PRACTICE 45 
